BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28819766)

  • 1. [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist].
    Müller AC; van Oorschot B; Micke O; Guckenberger M
    Strahlenther Onkol; 2018 Jan; 194(1):1-8. PubMed ID: 28819766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
    Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
    Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
    Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
    Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
    Miccio J; Johung K
    Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Radiation in Treatment of Renal Cell Carcinoma.
    Leeman JE
    Hematol Oncol Clin North Am; 2023 Oct; 37(5):921-924. PubMed ID: 37246085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS).
    Siva S; Louie AV; Kotecha R; Barber MN; Ali M; Zhang Z; Guckenberger M; Kim MS; Scorsetti M; Tree AC; Slotman BJ; Sahgal A; Lo SS
    Lancet Oncol; 2024 Jan; 25(1):e18-e28. PubMed ID: 38181809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma.
    Raj RK; Upadhyay R; Wang SJ; Singer EA; Dason S
    Curr Oncol; 2023 Dec; 30(12):10283-10298. PubMed ID: 38132383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA.
    Haque W; Verma V; Lewis GD; Lo SS; Butler EB; Teh BS
    Future Oncol; 2018 Apr; 14(9):819-827. PubMed ID: 29527938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for metastases to the kidney in patients with non-small cell lung cancer: a new treatment paradigm for durable palliation.
    Verma V; Simone CB
    Ann Palliat Med; 2017 Apr; 6(2):96-103. PubMed ID: 28480719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for renal-cell carcinoma.
    De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
    Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations.
    Nieder C; Gaspar LE; Ruysscher D; Guckenberger M; Mehta MP; Rusthoven CG; Sahgal A; Gkika E
    Strahlenther Onkol; 2018 May; 194(5):365-374. PubMed ID: 29362835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durable control of locally recurrent renal cell carcinoma using stereotactic body radiotherapy.
    Maclean J; Breau RH; Scheida N; Malone S
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for kidney cancer. Where do we stand?
    Sosa-Fajardo P; Blanco-Suarez JM; Pineda-Munguía Á; Rubí-Olea L; Peleteiro-Higuero P; Gajate P; Zafra-Martín J; Siva S; Bossi A; López-Campos F; Couñago F
    Int J Urol; 2023 May; 30(5):437-445. PubMed ID: 36746747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
    Miccio JA; Oladeru OT; Jun Ma S; Johung KL
    Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
    Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
    J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.
    Siva S; Pham D; Gill S; Corcoran NM; Foroudi F
    BJU Int; 2012 Dec; 110(11 Pt B):E737-43. PubMed ID: 23107102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
    Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
    Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Role of Radiotherapy for Renal-Cell Carcinoma: Review.
    Dengina N; Tsimafeyeu I; Mitin T
    Clin Genitourin Cancer; 2017 Apr; 15(2):183-187. PubMed ID: 27789182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A systematic review of radiotherapy for primary renal cell carcinoma].
    Gladilina IA; Shabanov MA; Kushlinskii NE; Bliganov PI; Sergeev AN
    Urologiia; 2022 Mar; (1):96-101. PubMed ID: 35274868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
    Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.